MedTrace Logo

Registry for Pulmonary Hypertension in China

NCT01417338 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3079

Last updated 2017-06-09

No results posted yet for this study

Summary

1. To characterize the demographics and clinical course of the patient population diagnosed as having WHO group I pulmonary arterial hypertension and WHO group IV pulmonary hypertension due to chronic thromboembolic pulmonary hypertension
2. To describe real-world outcome of Chinese patients with WHO group I pulmonary arterial hypertension and WHO group IV pulmonary hypertension due to chronic thromboembolic pulmonary hypertension
3. To evaluate differences in patient outcomes according to classification subgroup
4. To identify clinical predictors of long-term survival
5. To assess the relationship between targeted therapies for pulmonary arterial hypertension and patient outcomes

Conditions

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    lead OTHER

Principal Investigators

  • Jian-Guo He, M.D. · Fu Wai Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01417338 on ClinicalTrials.gov